大幸薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2016/03/25 | 1,402 | 1,402 | 1,373 | 1,384 | -19 | -1.4% | 46,400 |
2016/03/24 | 1,398 | 1,410 | 1,390 | 1,403 | +2 | +0.1% | 26,200 |
2016/03/23 | 1,413 | 1,426 | 1,392 | 1,401 | -11 | -0.8% | 32,400 |
2016/03/22 | 1,400 | 1,423 | 1,394 | 1,412 | +20 | +1.4% | 50,400 |
2016/03/18 | 1,383 | 1,396 | 1,368 | 1,392 | +6 | +0.4% | 43,900 |
2016/03/17 | 1,398 | 1,410 | 1,381 | 1,386 | -11 | -0.8% | 49,300 |
2016/03/16 | 1,405 | 1,411 | 1,387 | 1,397 | -15 | -1.1% | 65,900 |
2016/03/15 | 1,439 | 1,440 | 1,400 | 1,412 | -29 | -2% | 61,600 |
2016/03/14 | 1,438 | 1,462 | 1,427 | 1,441 | +24 | +1.7% | 58,000 |
2016/03/11 | 1,408 | 1,432 | 1,393 | 1,417 | -9 | -0.6% | 76,200 |
2016/03/10 | 1,405 | 1,438 | 1,405 | 1,426 | +34 | +2.4% | 52,400 |
2016/03/09 | 1,392 | 1,406 | 1,371 | 1,392 | -17 | -1.2% | 107,300 |
2016/03/08 | 1,412 | 1,427 | 1,383 | 1,409 | -8 | -0.6% | 77,300 |
2016/03/07 | 1,430 | 1,434 | 1,406 | 1,417 | -2 | -0.1% | 38,800 |
2016/03/04 | 1,394 | 1,429 | 1,386 | 1,419 | +11 | +0.8% | 52,700 |
2016/03/03 | 1,378 | 1,424 | 1,378 | 1,408 | +9 | +0.6% | 46,800 |
2016/03/02 | 1,400 | 1,410 | 1,380 | 1,399 | +56 | +4.2% | 85,300 |
2016/03/01 | 1,400 | 1,421 | 1,332 | 1,343 | -84 | -5.9% | 143,700 |
2016/02/29 | 1,374 | 1,455 | 1,356 | 1,427 | +94 | +7.1% | 225,600 |
2016/02/26 | 1,340 | 1,364 | 1,328 | 1,333 | +5 | +0.4% | 56,500 |
2016/02/25 | 1,305 | 1,346 | 1,302 | 1,328 | +11 | +0.8% | 89,800 |
2016/02/24 | 1,301 | 1,337 | 1,297 | 1,317 | -12 | -0.9% | 71,300 |
2016/02/23 | 1,315 | 1,350 | 1,315 | 1,329 | -16 | -1.2% | 50,900 |
2016/02/22 | 1,303 | 1,350 | 1,299 | 1,345 | +33 | +2.5% | 60,500 |
2016/02/19 | 1,320 | 1,338 | 1,300 | 1,312 | -20 | -1.5% | 51,100 |
2016/02/18 | 1,302 | 1,345 | 1,300 | 1,332 | +53 | +4.1% | 74,000 |
2016/02/17 | 1,318 | 1,332 | 1,239 | 1,279 | -51 | -3.8% | 140,300 |
2016/02/16 | 1,261 | 1,343 | 1,261 | 1,330 | +69 | +5.5% | 172,300 |
2016/02/15 | 1,021 | 1,276 | 1,012 | 1,261 | +150 | +13.5% | 332,300 |
2016/02/12 | 1,150 | 1,186 | 1,111 | 1,111 | -108 | -8.9% | 161,300 |
2016/02/10 | 1,258 | 1,278 | 1,206 | 1,219 | -39 | -3.1% | 111,900 |
2016/02/09 | 1,282 | 1,296 | 1,252 | 1,258 | -75 | -5.6% | 95,700 |
2016/02/08 | 1,272 | 1,352 | 1,272 | 1,333 | +55 | +4.3% | 123,100 |
2016/02/05 | 1,265 | 1,281 | 1,251 | 1,278 | -24 | -1.8% | 153,900 |
2016/02/04 | 1,390 | 1,400 | 1,284 | 1,302 | -77 | -5.6% | 275,600 |
2016/02/03 | 1,404 | 1,410 | 1,367 | 1,379 | -47 | -3.3% | 162,300 |
2016/02/02 | 1,427 | 1,475 | 1,412 | 1,426 | +24 | +1.7% | 285,600 |
2016/02/01 | 1,469 | 1,476 | 1,402 | 1,402 | -48 | -3.3% | 246,900 |
2016/01/29 | 1,387 | 1,450 | 1,355 | 1,450 | +49 | +3.5% | 245,100 |
2016/01/28 | 1,400 | 1,426 | 1,391 | 1,401 | -9 | -0.6% | 82,200 |
2016/01/27 | 1,413 | 1,418 | 1,394 | 1,410 | +29 | +2.1% | 96,900 |
2016/01/26 | 1,432 | 1,432 | 1,380 | 1,381 | -51 | -3.6% | 117,900 |
2016/01/25 | 1,439 | 1,488 | 1,414 | 1,432 | -3 | -0.2% | 116,800 |
2016/01/22 | 1,421 | 1,435 | 1,388 | 1,435 | +74 | +5.4% | 110,900 |
2016/01/21 | 1,438 | 1,457 | 1,361 | 1,361 | -107 | -7.3% | 147,000 |
2016/01/20 | 1,530 | 1,542 | 1,462 | 1,468 | -61 | -4% | 60,900 |
2016/01/19 | 1,535 | 1,558 | 1,520 | 1,529 | -20 | -1.3% | 60,700 |
2016/01/18 | 1,549 | 1,563 | 1,527 | 1,549 | -35 | -2.2% | 59,400 |
2016/01/15 | 1,622 | 1,623 | 1,580 | 1,584 | -39 | -2.4% | 87,300 |
2016/01/14 | 1,630 | 1,637 | 1,566 | 1,623 | -28 | -1.7% | 98,300 |
2301~
2350
件表示中 / 4021件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大幸薬品 | 31,800円 | +0.1% | -70.9% | 0.00% | 35.49倍 | 2.01倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
ステムリム | 31,500円 | - | - | 0.00% | - | 2.90倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
オンコリス | 71,200円 | +3771.0% | - | 0.00% | - | 12.41倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
ステラファーマ | 40,800円 | +4.8% | - | 0.00% | - | 4.33倍 |
|
ステラケミファ系、持分会社に。がん放射線治療用ホウ素医薬品が柱。適応拡大・海外展開注力 |
ラクオリア | 54,000円 | +25.1% | - | 0.00% | - | 2.11倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
市場注目の銘柄
チャート関連のコラム